Edwards Lifesciences
409 hedge funds and large institutions have $6.58B invested in Edwards Lifesciences in 2013 Q3 according to their latest regulatory filings, with 76 funds opening new positions, 141 increasing their positions, 126 reducing their positions, and 38 closing their positions.
Holders
409
Holders Change
+34
Holders Change %
+9.07%
% of All Funds
13.27%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.13%
New
76
Increased
141
Reduced
126
Closed
38
Calls
$133M
Puts
$64M
Net Calls
+$68.5M
Net Calls Change
-$6.23M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$126M |
| 2 |
2
Norges Bank
Oslo,
Norway
|
$95.8M |
| 3 |
3
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
$40.9M |
| 4 |
4
Two Sigma Investments
New York
|
$38M |
| 5 |
HM
5
HealthCor Management
New York
|
$34.8M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TH
451
Timber Hill
Greenwich,
Connecticut
| – | – | – | – |
|
452
Jennison Associates
New York
| – | – | – | – |
|
|
NES
453
New England Securities
New York
| $0 | 3 | – | – |
|
|
MFS
454
MSI Financial Services
Springfield,
Massachusetts
| $0 | 2 | +2 | New |
|